STRUCTURED WARRANTS ANNOUNCEMENT : INITIAL OFFERING
DPHARMA-C4: CW DUOPHARMA BIOTECH BERHAD (MIBB) |
Type | Announcement |
Subject | STRUCTURED WARRANTS ANNOUNCEMENT INITIAL OFFERING |
Description | MAYBANK INVESTMENT BANK BERHAD ("MAYBANK IB") PROPOSED ISSUANCE OF UP TO 100,000,000 EUROPEAN STYLE NON-COLLATERALISED CASH SETTLED CALL WARRANTS OVER THE ORDINARY SHARES OF DUOPHARMA BIOTECH BERHAD ("DPHARMA") ("DPHARMA SHARE(S)") ("DPHARMA-C4") |
We are pleased to announce the proposed issuance by Maybank IB of up to 100,000,000 European style non-collateralised cash settled call warrants over the DPHARMA Shares. DPHARMA-C4 is constituted by the Deed Poll dated 15 December 2021 executed by us for the Structured Warrants, as supplemented from time to time. DPHARMA-C4 is subject to the terms and conditions of the Base Prospectus dated 20 December 2021, the First Supplementary Base Prospectus dated 27 January 2022, the Second Supplementary Base Prospectus dated 11 April 2022 and the Term Sheet dated 5 August 2022. DPHARMA-C4 is to be listed on the Structured Warrants Board of Bursa Malaysia Securities Berhad. A summary of the principal terms of DPHARMA-C4 is set out in the attachment. |
Please refer attachment below.
Announcement Info
Company Name | DPHARMA-C4: CW DUOPHARMA BIOTECH BERHAD (MIBB) |
Stock Name | DPHARMA-C4 |
Date Announced | 05 Aug 2022 |
Category | General Announcement for PLC |
Reference Number | GA1-04082022-00045 |